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Erik van der Beek
Abstract
Objectives-To study the role of exposure,
atopy, and smoking in the development of
laboratory animal allergy (LAA) in a
retrospective cohort study.
Methods-Between 1977 and 1993, 225
people received a pre-employment
screening when they started a job at a
Dutch research institute where they were
going to work with laboratory animals.
After active follow up 136 ofthem (60.4%)
could be traced and were sent a question-
naire with extensive questions on allergic
symptoms, smoking habits, and job his-
tory. 122 people (89.7%) sent back a
completed questionnaire. Those who were
accepted for a job at the institute and did
not have allergic symptoms at the start of
the job were selected as cohort members.
After selecting people with complete data
on start and end date of jobs, exposure
intensity, atopy, and smoking, the cohort
consisted of 99 people with an average
time of follow up of 9.7 years. LAA was
defined as a positive response to a set of
questions in the questionnaire. The mean
number of hours a week a person was
exposed to laboratory animals at entry of
the cohort was used as a surrogate for
exposure, and was divided into four
categories.
Results-19 cohort members (19.2%) re-
ported LAA. More people with asthmatic
symptoms were found in the high expo-
sure categories. More atopic than non-
atopic people reported asthmatic
symptoms (13% v 6%). The mean time
until development of symptoms of LAA
was about 109 months in non-atopic
people (n=9), and 45 months in atopic
people (n=10) (t test; P<0.05). Time until
development of symptoms of LAA was
shorter at a higher intensity of exposure,
except for those exposed for less than two
hours a week. A proportional hazard
regression analysis showed that exposure
and atopy were significant determinants
of LAA. An increased relative risk (RR)
was found for non-atopic people exposed
to laboratory animal allergens for more
than two hours a week. Atopic people had
an even higher risk when exposed to labo-
ratory animals for more than two hours a
week (RR above 7.3). Sex, smoking, and
age were not risk factors. More atopic
than non-atopic people were absent from
work or transferred because of allergies.
Conclusions-This study showed that ex-
posure and atopy are significant predic-
tors ofLAA and that the risk ofdeveloping
LAA remained present for a much longer
period (>3 y) than considered before.
(Occup Environ Med 1997;54:830-835)
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People who work with laboratory animals are at
risk of developing an allergy to the animals they
work with. Prevalence rates of 10%-30% have
been found, and give an impression of the
magnitude of the health risks.' 2 Urinary
proteins of laboratory animals are the cause of
laboratory animal allergy (LAA). ' Mild symp-
toms of LAA are rhinitis, and skin and eye
reactions.' 3'4 Asthma is a more severe form
that develops in about 17%-71% of cases of
LAA.1 There are some suggestions that most
cases develop LAA two to three years from ini-
tial exposure to the allergen.' 2 However, the
evidence for this is limited and is mainly based
on clinical data. No unbiased estimates of time
till sensitisation are available from well de-
signed epidemiological studies.
Allergen concentrations are known to vary
considerably, and depend on stock density,
tasks performed, ventilation rates,5 cage design,
bedding type, air filtration, and humidity.2
Despite these findings, few studies focused on
the relation between exposure intensity and
duration and development of LAA. Recent
findings from a cross sectional study performed
suggest that work related symptoms are related
to exposure intensity (expressed either in terms
of dust or aeroallergen concentrations) at the
time of onset of symptoms of LAA.6 Generally,
crude proxies have been used to characterise
exposure to allergens. In one cross sectional
study the degree of exposure to animals had a
positive and significant association with the
presence of LAA, but duration of employment
was not related to LAA.' Renstrom et at exam-
ined the differences for several response
variables in an exposed and a matched
non-exposed group (36 pairs) which were
sampled out of a large group of laboratory ani-
mal workers. After two years of follow up no
clear differences were found between the two
groups in incidence of LAA, specific IgE, and
atopy. Work related allergic symptoms were
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reported more often at follow up. Several stud-
ies have shown that atopic people are at higher
risk ofdeveloping LAA. ' 6 7 9 One study showed
that people with atopy develop LAA earlier
than those without.3 Furthermore it has been
mentioned that atopic people are more likely to
develop the allergy in a more severe form.' 4 6
Smoking is also suggested to be related to
LAA, possibly by increasing mucosal transport
of allergens, but evidence is not conclusive.'
Age and sex are said to be effect modifiers in
the development of occupational asthma as
well, but have hardly been studied in relation to
LAA.
Most studies published have cross sectional
designs and potentially have several forms of
bias. A recently conducted cross sectional
study in laboratory animal workers showed that
a clear exposure-response relation between
exposure to urinary proteins and allergic sensi-
tisation could only be found in workers
employed for less than four years, probably
because of the healthy worker effect.'" Quanti-
tative unbiased estimates of these factors are
therefore not available. Moreover, in cohort
studies of laboratory animal workers there was
a shorter period of follow up than the time
untill sensitisation.378
This cohort was followed up for longer than
most other cohorts of laboratory animal work-
ers and all participants were free of symptoms
at the start of follow up. The time after which
symptoms of LAA developed was known and
this allowed calculation of incident density
ratios (IDRs). The primary aim of this study
was to determine the effect of exposure inten-
sity on the development ofLAA and the role of
other variables, such as atopy, smoking, calen-
dar period, sex, and age.
Methods
Between 1977 and 1993, 225 people under-
went pre-employment screening for a job with
laboratory animals at three parts of a Dutch
research institute. Pre-employment screening
was done by the Allergy Centre of Utrecht and
consisted of a full respiratory and allergy
anamnesis. Skin prick tests to house dust mite,
pollen, and several animals, were performed at
the Allergy Centre. All participants were tested
for cats, dogs, or animals to which they had
been exposed. In 1993 and 1994 home
addresses of these people were traced. Person-
nel records of the Dutch Research Institute
were used, as well as registries of the pension
fund. For the remaining cases, a CD-ROM tel-
ephone guide was consulted within 30 km of
the laboratories. For 136 people (60.4%)
addresses were found and they were sent a
questionnaire with extensive questions on work
related allergic symptoms, smoking habits, and
job history. One hundred and twenty two peo-
ple (89.7%) returned the questionnaire. People
with allergic symptoms before getting the job,
and those who finally did not get a job at the
institute, were excluded from the cohort.
Traced people with incomplete data on their
job history (date starting or ending jobs),
exposure, atopy, or smoking were excluded
from further analyses. Therefore the cohort
used in the analyses included 99 symptom free
participants (72.8%). The date a person
started a job at the institute was defined as
cohort entry date.
ALLERGIC SYMPTOMS
The self administered questionnaire contained
questions about personal history of allergic
symptoms to common allergens, history of
allergic symptoms to laboratory animals, and
intensity of contact with laboratory animals,
and has been used earlier in a study on
LAA.'0 " Allergic symptoms due to working
with laboratory animals were defined as the
presence of allergy during working hours, or
after contact with laboratory animals (Do you
have any of the following symptoms during
work, after contact with laboratory animals
(please specify animal species)?) Self reported
allergic symptoms were divided into four
groups: nasal symptoms, defined as sneezing
and runny nose (production of nasal secre-
tions); skin symptoms defined as itching or red
skin; eye symptoms, defined as itching or
smarting eyes; and asthma, defined as presence
of shortness of breath and wheezing. The
questionnaire used came from another study in
laboratory animal workers." " The sensitisa-
tion period was defined as the period between
the first exposure to laboratory animals and the
first occurrence of symptoms of LAA.
EXPOSURE
As a surrogate for exposure intensity the mean
number of hours a week a person was exposed
to laboratory animals at baseline was used.
Exposure intensity was divided into four
categories in most analyses with roughly
similar numbers of participants. The exposure
intensity categories were: <2 hours a week,
2-< 15 hours a week, 15-<38 hours a week, and
¢ 38 hours a week on average. Potential
exposure before cohort entry was omitted.
Some participants had been exposed during
training, but the average exposure duration
during training was less than three months.
OTHER VARIABLES
People were atopic if they had a positive skin
prick test at baseline to house dust mite, pollen,
or an animal (cat, dog, or other animal they had
been exposed to outside the workplace). A
recently published paper showed that atopy
defined on the basis of atopic sensitisation to
other animals was the best predictor of LAA."
Smoking at baseline was used in the analyses.
No distinction was made between smoking
cigarettes, cigars, or a pipe. Three calendar
periods for those entering the cohort were
distinguished with baseline date: 1973-80,
1981-6 and 1987-94.
ANALYSES
Statistical analyses were performed with Statis-
tical Analyses Software (SAS). Mean and
median sensitisation periods were calculated
with Proc Univariate. Incidence density rates
were calculated by dividing the number of
cases of LAA by the sum of person-years for
each person from the entry date to the cohort
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until the end ofthe follow up (1993-4), or until
the first symptoms ofLAA were reported. Sur-
vival analyses were performed with propor-
tional hazard techniques.
Results
Of the 225 people who underwent a pre-
employment medical, 89 (39.6%) could not be
traced and 136 were sent a questionnaire.
Eleven (8.1 %) reported personal reasons for
refusing participation and three (2.2%) had
died. Of the 122 people who completed the
questionnaire, 13 were excluded from the
cohort because they reported symptoms of
LAA at the pre-employment medical9 or finally
did not start working at the institute. Nine
people with incomplete data on when starting
or ending jobs, exposure intensity, atopy, or
smoking were also excluded from further
analyses. This resulted in a cohort of 99 people
(72.8%). Since baseline data were available for
all 225, the prevalence of atopy could be stud-
ied in cohort members and those who were not
included in the cohort. Prevalence of atopy did
not differ significantly between the two groups
(31.2% (31/99) v 40.2 (49/122) respectively,
Fisher's exact test, P>0.15). Similar inclusion
criteria were applied in this comparison.
ALLERGIC SYMPTOMS
Table 1 shows general characteristics of the
cohort. Nineteen people reported JAA, result-
ing in a incidence ofLAA of 19.2%. The inci-
dence in the first year of employment was
4.0%-that is, four of the LAA cases. Seven-
teen of the LAA cases (89.5%) reported an
allergy to rats, seven (36.8%) to mice, four
(21.1%) to guinea pigs, and three (15.8%) to
rabbits (table 1). Most cases reported nose or
skin symptoms. Asthmatic symptoms were
reported by 42.1% of the LAA cases. Asth-
matic symptoms were always, except for one
subject, accompanied by other symptoms. Peo-
ple with asthmatic symptoms were only found
among people who worked with laboratory
animals for more than two hours a week on
average. More atopic than non-atopic people
developed asthmatic symptoms (13% v 6%).
SENSITISATION PERIOD
The mean sensitisation period for non-atopic
people with LAA (n=9) was about 109 months
and differed significantly from the mean sensi-
Table 1 General descriptive information on 99 laboratory
animal workers
n %
Participants 99 100
Female workers 44 44.4
Atopic workers 31 31.3
Smokers at cohort entry 47 47.5
LAA 19 19.2
Rat allergy 17 17.3
Mouse allergy* 7 7.1
Guinea pig allergy* 4 4.1
Rabbit allergy* 3 3.1
Work related allergy symptoms*:
Rhinitis* 14 14.3
Asthma* 8 8.2
Eye* 11 11.2
Skin* 15 15.3
Age at cohort entry (mean (range)) 25 16-44
*n=98 due to missing information in one of the questionnaires.
tisation period of atopic people with LAA
(n= 10), which was about 45 months (Kruskal-
Wallis, P<0.05). The mean sensitisation period
decreased with increasing exposure intensity,
except for the lowest exposure category (table
2). The two highest exposed categories (expo-
sure intensity ¢ 15 hours a week) had a signifi-
cantly shorter mean sensitisation period than
the two categories with the lowest exposure
(exposure intensity < 15 hours a week; Kruskal
Wallis test, P<0.05). Thirteen ofthe 23 cases of
LAA were referred to the Allergy Centre of
Utrecht by the Occupational Health Service
because these workers developed symptoms of
LAA. For these cases, the difference between
the onset of symptoms of LAA reported by
questionnaire and clinically confirmed LAA
reported in the medical files was two years
maximum, with a Pearson correlation of >0.90
(P<0.05).
INCIDENCE DENSITY RATES
The overall IDR was 1.97 cases per 100
person-years (table 3). The IDR increased with
increasing exposure intensity. The IDR for
atopic people was more than three times higher
than for non-atopic people. Smokers had a
higher IDR than non-smokers. Men seemed to
have a higher IDR than women. The risk of
developing LAA seemed to increase with time,
as indicated by the IDR by calendar period.
SURVIVAL ANALYSIS
Table 4 shows the characteristics of the
exposure intensity categories. An analysis with
exposure intensity, atopy, smoking at baseline,
calendar period, sex, and age in one model,
Table 2 Mean and median time until development of
LAA symptoms (in month) for 19 laboratory animal
workers with self reported LAA
LAA cases
(n) Mean Median Range
All cases 19 76 63 <1-270
Non-atopic cases 9 109 98 7-270
Atopic cases 10 45 27 <1-117
Exposure < 2 h/week 2 83 83 30-36
2S Exposure<15
h/week 6 133 113 83-270
15<_ Exposure<38
h/week 7 58 56 1-192
Exposurek38 h/week 4 16 14 <1-36
Table 3 Number ofLAA cases, sum ofperson-years of
follow up, and incidence density ratios (IDRs);overall, by
atopic status, sex, exposure, and smoking at cohort entry
LAA Sum of IDR cases/100
cases (n) person- years person-years
All cases 19 964.6 1.97
Non-atopic cases 9 722.6 1.25
Atopic cases 10 242.0 4.13
Exposure< 2h/week 2 232.2 0.86
2 Exposure<15
h/week 6 210.3 2.85
15,Exposure<38
h/week 7 309.8 2.26
Exposure- 35
h/week 4 212.3 1.88
Non-smokers 10 542.8 1.84
Smokers 9 421.8 2.13
Men 10 496.0 2.02
Women 9 469.0 1.92
1973-80 7 461.6 1.52
1981-6 9 411.8 2.19
1987-94 3 91.3 3.29
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Table 4 Risk factors ofLAA and LAA related endpoints by exposure intensity categories
for 99 laboratory animal workers
Exposure < 2 2< Exposure 15< Exposure Exposure B38
h/week <15 h/week <38 h/week h/week
Total in category 25 25 25 24
LAAcases 2 (8) 6 (24) 7 (28) 4 (17)
Asthma 0 (0) 2 (8) 3 (12) 3 (13)
Atopy 11 (44) 6 (24) 7 (28) 7 (29)
Women 6 (24) 11 (44) 12 (48) 15 (63)
Smoking at baseline 9 (36) 12 (48) 13 (52) 13 (54)
Absent from work due to
symptoms* 0 (0) 0 (0) 3 (13) 3 (13)
Transferred to another job* 0 (0) 1 (4) 3 (13) 4 (17)
Age (mean (range)) 27 (17-24) 30 (20-44) 23 (17-42) 20 (16-32)
*n=98 due to missing information in one of the questionnaires.
Table S Results from simple univariate proportional
hazard regression analyses ofsymptoms ofLAA by
exposure and potential confounders in 99 laboratory animal
workers
LAAln RR (95% CI)
Exposure<2 2/25 1.0 -
2<Exposure<15 h/week 6/6 5.3* (1.0 to 27.6)
15<Exposure<38
h/week 7/25 5.it (0.9 to 28.0)
Exposurek38 h/week 4/24 3.6 (0.6 to 21.5)
Non-atopic cases 9/68 1.0
Atopic cases 10/31 4.2* (1.5 to 11.3)
Non-smokers 10/52 1.0 -
Smokers 9/47 0.8 (0.3 to 2.1)
1973-80 7/35 1.0 -
1981-6 9/38 1.6 (0.5 to 4.6)
1987-94 3/26 1.8 (0.4 to 8.3)
*P<0.05; tP<0.10.
showed that sex and age were not significantly
related to LAA, with relative risks (RR) of
0.8 (P=0.71) and 1.0 (P=0.49) respectively.
Therefore age and sex were excluded from
subsequent models. A weak period effect
seemed present. The risk of developing LAA
was, however, non-significantly increased in
people who started their job at the institute at a
later calendar date.
Table 5 shows the results of the remaining
model. The RRs for the four exposure catego-
ries were 1.0, 5.3, 5.1, and 3.6 respectively. The
relative risk for the category with an exposure
intensity between two and 15 hours a week was
significant, and the RR for the category with an
exposure intensity between 15 and 38 hours a
week was of borderline significance. When
these four exposure intensity categories were
rearranged into two categories, a non-exposed
category (exposure intensity < 15 hours a week)
and an exposed category (exposure intensity
3e 15 hours a week) a corrected RR of 1.5 was
found (P=0.47). Although most atopic people
Table 6 Multiple proportional hazard regression ofLAA on exposure correctedfor atopy(only first model) and smoking,for the whole population and stratified by atopy in 99
laboratory animal workers
All workers Non-atopic cases Atopic cases
RR (95% CI) RR (95% CI) RR (95% CI
Reference category 1.0 - 1.0 - 1.0
2<Exposure<15 5.3t
h/week (1.0 to 25.9) 2.5 (0.3 to 24.5) 8.Ot (0.8 to 79.5)
15 <Exposure<38 51t
h/week (0.9 to 22.6) 2.5 (0.2 to 24.8) 7.3t (0.7 to 72.5)
Exposure¢38 h/week 3.6 (0.5 to 17.6) 1.1 (0.1 to 18.5) 8.3t (0.8 to 85.7)
Smokers 0.8 (0.3 to 2.2) 1.6 (0.4 to 6.9) 0.6 (0.2 to 2.1)
Atopic cases 3.8* - -
*P<0.05, tP<0.10
were in the non-exposed category, the RR was
still higher in the exposed category.
Survival analysis assumes proportionality of
survival curves for all exposure categories. This
implies that the curves of the four exposure
categories should not cross. In most cases these
assumptions were not violated although after
about 100 months of follow up curves crossed
in some analyses for some exposure categories.
An analysis limited to 100 months of follow up
did not result in different risk estimates.
People with atopy were at greater risk of
developing LAA. A relative risk of 4.2 (P<0.05,
95% confidence interval (95% CI) 1.5 to 11.3)
was found for atopy, corrected for exposure
intensity, calendar period, and smoking (table
5). Table 6 shows a separate analysis for atopic
and non-atopic people. Atopic people seemed
to have an increased risk of developing LAA
when exposed. The RRs for the three exposure
intensities were 8.0, 7.3, and 8.3 respectively.
For non-atopic people, the pattern was about
the same as for atopic people; but RRs were
lower.
When participants with an exposure inten-
sity of less than 15 hours a week were
compared with participants with a higher
exposure intensity, a difference was found in
the number of people who reported absence
from work because of allergic symptoms (0% v
13%). The proportion of people who were
transferred to another task or job because of
allergic symptoms also differed among these
two categories (respectively 2% v 15%).
A significant difference in the number of
people who were transferred to another task or
job because of their symptoms ofLAA was also
found between atopic and non-atopic people
(16% v 5% respectively, P<0.10). The differ-
ence between atopic and non-atopic people in
absenteeism from work because of allergic
symptoms was small: 10% v 5% respectively.
Discussion
This study shows that both non-atopic and
atopic people seemed to have an increased risk
related to exposure intensity when exposed to
laboratory animal allergens. Atopic people
developed LAA significantly earlier and in
more severe forms (asthma) than non-atopic
people. The time until development of the first
symptoms ofLAA was longer than reported in
previous studies.' 2 In this study the mean time
until development ofthe first symptoms was 76
months, with a maximum of 270 months. The
risk of developing LAA remained present, even
after three years of exposure to laboratory ani-
mals.
This study had possible selection bias
because of loss to follow up, which could be
related to LAA or the allergen exposure. Of
225 people who were eligible to participate in
this study, 122 completed the questionnaire.
Most of the non-response (86.4%) occurred
because the address was unknown, despite
active follow up. Other causes of non-response
were a change in name because some women
married, and some women were not expected
to pay a pension contribution and were
therefore not registered by the pension fund. A
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few people had emigrated, particularly re-
searchers. People were also not recorded in the
CD-ROM telephone guide. Despite high rates
of loss to follow up, selection bias seems
unlikely, as a similar prevalence of atopy was
found in non-participants and participants.
Also, the distribution of men and women was
similar in non-participants and participants.
Participants and non-participants were evenly
distributed over the three cohort entry periods.
Although non-response was considerable, the
final cohort still consisted of 99 people (72.8%
of the people who were sent a questionnaire),
many participants in comparison with other
cohort studies.4 8
People at risk were followed up until the
development of LAA. The presence of the first
symptoms of LAA was determined by ques-
tionnaire. This could have been vulnerable to
responder bias. However, a comparison of the
value of the self reported information on the
time a participant developed the first symp-
toms ofLAA with medical information present
at the Allergy Clinic showed that of all 23 cases
of LAA, 13 were again seen by the medical
specialist (BM) during the follow up period.
For all these cases LAA was confirmed
clinically by SPT or by serological testing. For
these 13 cases, the difference between the time
of onset of symptoms reported by question-
naire and reported in the medical files was two
years at most and the correlation between the
two sources of information was high (Pearson
correlation >0.90). These results for a sub-
group of cases of LAA suggest that the self
reported information was valid for presence
and onset of LAA. For 10 cases, no additional
information could be found in the records of
the Allergy Centre, probably because they were
not referred to this clinic by the occupational
health service. No cohort members who did
not report symptoms in the questionnaire dur-
ing the follow up were seen at the Allergy Cen-
tre after the initial evaluation. Although this
cannot be seen as a complete evaluation of the
validity of the questionnaire used, it does
suggest that recall ofsymptoms agreed with the
clinical evaluation of symptoms made during
the follow up and that no over or underreport-
ing occurred. It also suggests that those who
developed symptoms during the follow up
attributed those correctly to working with
laboratory animals. This also implies that the
relations reported can most probably not be
explained by the presence of recall bias. This
also seems unlikely as the relation with atopy in
this study is comparable with what is com-
monly found in the scientific literature.'0 113
The incidence ofLAA (19.2%) was compa-
rable with figures given in other studies.' 2 6
The incidence in the first year was already
4.0%. Botham et at' reported a decrease in
incidence after two and three years of follow
up. However, they did not allow for a reduction
of the population at risk after the first year of
follow up due to development ofLAA in some
workers. Those who developed LAA during the
first year of follow up are not at risk any more
during subsequent years and should be re-
moved from the calculations of risk in the sec-
ond and third year. Recalculation from their
tables shows a slight increase in incidence in
the second and third year of follow up
compared with the first year. In our study labo-
ratory animal workers were still at risk after
having worked for three years with animals at
the institute, although the risk decreased after
this period.
In this study an increased risk was found for
people exposed to laboratory animals for more
than two hours a week. The risk decreased for
people exposed for more hours a week.This
could probably be explained by a healthy
worker effect. The number of people who were
transferred to another task or job because of
allergic symptoms increased with increasing
exposure intensity (0%, 4%, 13%, and 17%
respectively). Kibby et at also reported a posi-
tive association between exposure intensity and
the presence of LAA in their prevalence study
(prevalence ratio (PR) 1.75; 95% CI, 1.06 to
2.39; X2=4.97; p=0.03). In their study exposure
intensity was the self reported number ofhours
a day, days a week, and weeks in six months of
contact with laboratory animals.
In our study time until onset of the first
symptoms ofLAA was shorter at higher inten-
sitirs of exposure, except for the category with
lowest exposure. The exception could be
explained by the highest number of atopic peo-
ple in this category and the few cases ofLAA in
this category. People exposed more intensely
developed asthmatic symptoms faster. Expo-
sure intensity was a surrogate for the exposure
level. It was self reported in the questionnaire
and could therefore be biased. This surrogate
of exposure has been used in other studies as
well. Results from the study by Hollander et al'0
suggest that this surrogate is strongly corre-
lated with the exposure proxy that performed
best in the analysis; the number of hours that a
person worked with rats multiplied by the anti-
gen level. Exposure before the first job was not
considered extensively because all participants
were symptom free at the start of this job.
Atopy seemed to be strongly related to the
development of LAA. A significant RR of 4.2
was found for atopy in a multiple regression
model with exposure intensity, smoking, and
calendar period. In other studies comparable
RRs were reported.7 8 In the prospective study
of Botham et al,' LAA was defined with
questionnaires annually. Their data were con-
firmed clinically only in a few cases. In that
study more non-atopic people developed LAA
after two and three years. During the first year
19%-43% of atopic people developed LAA
compared with 3%-6% of the non-atopic peo-
ple, but rates became similar during later years.
There were some indications that atopy was an
effect modifier. In our study atopic people
developed symptoms ofLAA earlier than non-
atopic people. Atopic people also developed
LAA more often than non-atopic people.
Atopic people had a higher overall increased
risk than non-atopic people after being exposed
to laboratory animal allergens. A higher
percentage of people with asthmatic symptoms
was found among atopic people than non-
atopic people. This has been confirmed by a
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few other studies.2 4612 Also more atopic
people were absent from work or transferred to
another job because of symptoms of LAA.
Most atopic people were found in the non-
exposed category (exposure intensity <2
h/week). This might be indicative of self selec-
tion among the participants. It is also possible
that advice of the Allergy Centre, where the
pre-employment medicals were performed,
was responsible for this result. Unfortunately a
detailed comparison of the results of this study
with other studies is not possible, because the
definition of atopy differs considerably be-
tween studies.
Most follow up studies were based on an
assumed sensitisation period of about three
years.3 7 8 However, our study results showed
on average a longer sensitisation period. This
could be the result of survivor bias, due to
using a cohort selected by means of a
pre-employment screening, and excluding peo-
ple with symptoms of LAA. Also some other
studies reported a longer time until develop-
ment of the first symptoms ofLAA than is gen-
erally assumed (Lutsky and Neuman, 1975,
Neuman and Lutsky, 1976, Hook et al, 1984).
Few studies gave proper estimates of the mean
time to sensitisation, because the duration of
follow up was too short or the series was of
more severely affected patients, which could
lead to serious bias. Therefore, these studies
were not able to estimate correct or unbiased
RRs. Furthermore, it seems justified to suggest
that in follow up studies a longer follow up
should be considered. More research on deter-
minants of the duration of the sensitisation
period would be of interest.
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